Parkinson Disease(PD)
11
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction
Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
A Smartphone Application for Neurology and Telemedicine
AR Stimulation Effects on Gait, Anxiety, and Brain Connectivity in Parkinson's Disease
Cycling and Treadmill With Dual Task for Parkinson's Disease Improvement
Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training
Gait Initiation Difficulty and Anticipatory Postural Adjustment (APA) Impairment in People With PD - Evaluation and Training
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
The Stanford Parkinson's Disease Plasma Study